Carregant...
Treating systemic lupus erythematosus in the 21st century: new drugs and new perspectives on old drugs
Besides treating acute flares, the management of SLE should aim at preventing organ damage accrual and drug-associated harms, improving health-related quality of life and prolonging survival. At present, therapy is based on combinations of antimalarials (mainly HCQ), considered the backbone of SLE t...
Guardat en:
| Publicat a: | Rheumatology (Oxford) |
|---|---|
| Autors principals: | , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Oxford University Press
2020
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7719039/ https://ncbi.nlm.nih.gov/pubmed/33280011 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/rheumatology/keaa403 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|